封面
市場調查報告書
商品編碼
2058932

2034年強迫症(OCD)數位治療藥物市場預測:按治療方法、給藥平台、經營模式、最終用戶和地區分類的全球分析

OCD-Focused Digital Therapeutics Market Forecasts to 2034 - Global Analysis By Therapeutic Approach, Delivery Platform, Business Model, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,全球專門用於治療強迫症 (OCD) 的數位療法市場預計將在 2026 年達到 18 億美元,並在預測期內以 8.1% 的複合年成長率成長,到 2034 年達到 33 億美元。

專為強迫症 (OCD) 設計的數位化療法是基於技術的治療方法,旨在幫助患者運用認知行為療法 (CBT) 和暴露療法(包括反應預防)等成熟方法控制症狀。這些工具透過應用程式和線上平台提供,包含引導式模組、自適應任務和即時回饋,從而擴大了治療範圍,並支持患者在診所外進行持續治療。進度追蹤、分析和與臨床醫生溝通等功能可實現持續監測和及時調整。這些工具將心理學與引人入勝的設計相結合,能夠提高治療依從性,彌補治療缺口,並在與面對面治療結合使用時帶來持續的療效。總而言之,這些工具具有高度擴充性、經濟實惠,並且能夠靈活地應用於全球不同的患者群體和醫療環境。

根據發表在《自然》雜誌上的一項隨機臨床試驗,120名患有強迫症(OCD)的美國成年人被隨機分配接受為期12週的基於應用程式的指導式認知行為療法(CBT)。研究證實,患者的症狀顯著減輕,並顯示數位化CBT可以解決治療師短缺和治療延誤等障礙。

強迫症盛行率增加

強迫症(OCD)患者數量的不斷成長,顯著提升了對OCD數位化治療方法的需求。公眾意識的提高、篩檢方法的改進以及社會歧視的減少,促使更多患者尋求協助。然而,由於費用高昂和訓練有素的專業人員短缺,傳統療法的普及仍然有限。數位化解決方案透過提供遠端、結構化的治療方案,正在彌合這一差距。此外,政府對精神健康保健的日益重視也推動了數位化解決方案的普及。隨著早期診斷的日益普遍,全球醫療保健系統對便利、擴充性的數位化治療方案的需求也在穩步成長。

臨床檢驗有限和監管方面的挑戰

針對強迫症的數位療法面臨的主要挑戰在於缺乏可靠的臨床證據和複雜的核准流程。許多專為強迫症設計的工具尚未經過廣泛的臨床試驗來證明其長期療效和安全性。監管機構通常會提出類似於藥品核准的嚴格要求,這可能會阻礙創新和商業化。各國法規的差異進一步增加了企業合規的難度。這導致臨床醫生和使用者猶豫不決,並降低了他們對這些解決方案的信心。因此,不明確的檢驗標準和監管障礙持續限制數位療法市場的廣泛應用和成長。

個人化和人工智慧技術的進步

人工智慧的進步為強迫症(OCD)的個人化數位療法開啟了新的可能性。這些系統可以評估使用者的行為模式,並提供針對個別強迫症患者的客製化介入措施。透過採用認知行為療法等方法,該平台可以調整治療內容並提供即時回饋。個人化的體驗能夠提高患者的參與度並改善治療效果。隨著人工智慧技術的不斷發展,數位療法將變得更加靈活和高效,為患者和醫療專業人員帶來更大的價值,同時推動心理健康治療領域的創新和發展。

激烈的市場競爭與市場分散

激烈的競爭和市場分散化對強迫症(OCD)的數位療法構成威脅。許多公司提供的OCD解決方案功能相似,難以實現差異化。這種擁擠的市場環境可能導致定價難題和利潤率下降。此外,各平台缺乏統一標準也會讓使用者和臨床醫師感到困惑。隨著競爭加劇,小規模公司將難以生存,而主導企業將獲得更大的控制權。這種不平衡可能會扼殺創新,阻礙數位療法領域的永續發展。

新型冠狀病毒(COVID-19)的影響:

新冠疫情透過增加對心理健康支持的需求,在推動強迫症(OCD)數位療法市場擴張方面發揮了決定性作用。壓力增加、社交隔離和衛生擔憂加劇了強迫症患者的症狀。封鎖措施限制了患者獲得傳統面對面治療的機會,促使他們更多地使用數位治療平台。患者和醫療服務提供者都更加依賴遠端醫療和行動解決方案。此外,對數位醫療的投資增加和認知度的提高也推動了創新,促進了數位療法在全球心理健康領域的持續成長和廣泛應用。

在預測期內,基於認知行為療法 (CBT) 的數位模組細分市場預計將佔據最大佔有率。

由於認知行為療法(CBT)的可靠性和有效性已得到證實,預計在預測期內,基於CBT的數位化模組將佔據最大的市場佔有率。這些解決方案提供了一種結構化的、經科學檢驗的方法來應對強迫症的症狀。它們的柔軟性使其既可以獨立使用,也可以與專業指導結合使用,從而提高了使用者的易用性。一致的療效、標準化的框架以及在各種數位化平台上的便利部署,鞏固了其市場地位。因此,它們獲得了廣泛的信任和應用,使其成為不斷發展的強迫症數位化治療領域的領先組成部分。

在預測期內,免費增值到高級升級模式細分市場預計將呈現最高的複合年成長率。

在預測期內,由於其在易用性和盈利性之間的有效平衡,免費增值到付費升級模式預計將呈現最高的成長率。透過提供免費的入門級服務,強迫症(OCD)患者可以無經濟負擔地試用平台。一旦用戶體驗到其益處,許多人會升級到付費計劃,以尋求更多功能和個人化護理。這種模式提高了用戶參與度,建立了信任,並鼓勵長期使用。其柔軟性和擴充性使其非常適合現代數位行為,從而推動了快速普及,並使其成為數位治療生態系統中的關鍵成長領域。

市佔率最大的地區:

在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其完善的醫療保健體系和先進數位解決方案的廣泛應用。北美地區對強迫症的認知度較高,因此對創新治療方法的需求不斷成長。該地區擁有有利的監管環境和對數位醫療技術的巨額投資。將認知行為療法 (CBT) 等成熟方法整合到數位平台中,將進一步提升治療效果。此外,智慧型手機和網路的普及,以及保險的支持,將加速這些療法的應用,並進一步鞏固北美在市場上的主導地位。

複合年成長率最高的地區:

在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於技術應用的普及和醫療保健系統的改進。強迫症病例的增加以及人們對心理健康意識的提高,正在推動對便利治療方法的需求。印度和中國等國家正積極透過政府主導的措施和投資來推廣數位醫療。網路連線的改善和智慧型手機的普及進一步促進了市場擴張。該地區擁有龐大的未充分醫療服務人群,且對數位解決方案的接受度不斷提高,這為快速且永續的成長提供了巨大的機會。

免費客製化服務:

所有購買此報告的客戶均可享受以下免費自訂選項之一:

  • 企業概況
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域細分
    • 應客戶要求,我們提供主要國家的市場估算和預測,以及複合年成長率(註:需進行可行性檢查)。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章:執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球強迫症(OCD)數位療法市場:依治療方法分類

  • 基於CBT的數位模組
  • 以ERP為中心的平台
  • 神經回饋解決方案
  • AI驅動的個性化引擎

第6章 全球強迫症(OCD)數位療法市場:依分銷平台分類

  • 行動應用介面
  • Web入口網站平台
  • 身臨其境型VR/AR治療系統
  • 穿戴式裝置連接的強迫症工具

第7章:全球強迫症(OCD)數位療法市場:依經營模式

  • 患者訂閱計劃
  • 單次許可證購買
  • 免費增值到高級版的升級模式
  • 機構授權協議

第8章 全球強迫症(OCD)數位療法市場:以最終用戶分類

  • 患有強迫症的兒童和青少年
  • 成年強迫症患者
  • 臨床專家
  • 組織採用者

第9章 全球強迫症(OCD)數位療法市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章:公司簡介

  • nOCD
  • LiveOCD Free
  • OCFree
  • GGtude
  • OCD.app
  • Treat My OCD
  • Quirk Health
  • Anxiety Canada
  • IOCDF
  • Woebot
  • Sanvello
  • MindShift CBT
  • OCD Challenge
  • BT Steps
  • Exposure Tracker
  • Dare Health
  • ClearFear
  • GGOC-AD
Product Code: SMRC36494

According to Stratistics MRC, the Global OCD-Focused Digital Therapeutics Market is accounted for $1.8 billion in 2026 and is expected to reach $3.3 billion by 2034 growing at a CAGR of 8.1% during the forecast period. Digital therapeutics tailored for obsessive-compulsive disorder are technology-based treatments that help patients manage symptoms using proven methods like CBT and exposure with response prevention. Delivered through apps or online platforms, they offer guided modules, adaptive tasks, and instant feedback, increasing access and supporting consistent care outside clinics. Features such as tracking, insights, and links to clinicians allow ongoing oversight and timely adjustments. Integrating psychology with engaging design, these tools improve adherence, bridge care gaps, and work alongside in-person therapy to achieve sustained improvements. Overall, they are scalable, affordable, and flexible for use across varied populations and healthcare environments globally.

According to a randomized clinical trial published in Nature, 120 U.S. adults with OCD were randomized to 12 weeks of coach-guided app-based CBT. The study found significant symptom reduction, demonstrating that digital CBT can address barriers such as therapist shortages and treatment delays.

Market Dynamics:

Driver:

Rising prevalence of obsessive-compulsive disorder

The growing number of individuals diagnosed with Obsessive-Compulsive Disorder is significantly fueling the demand for digital therapeutics designed for OCD. Increased awareness, better screening methods, and declining stigma are motivating more patients to seek help. Yet, access to conventional therapy remains limited because of high costs and a shortage of trained professionals. Digital solutions bridge this gap by providing remote, structured treatment programs. Additionally, rising government focus on mental healthcare is supporting adoption. As early diagnosis becomes more common, the need for accessible and scalable digital treatment options is steadily increasing across global healthcare systems.

Restraint:

Limited clinical validation and regulatory challenges

A major limitation for OCD-focused digital therapeutics is the lack of strong clinical evidence and complex approval processes. Many tools designed for Obsessive-Compulsive Disorder have not undergone extensive trials to prove their long-term effectiveness and safety. Regulatory authorities often impose strict requirements, similar to drug approvals, which can slow down innovation and commercialization. Differences in regulations across countries further complicate compliance for companies. This creates hesitation among clinicians and users, reducing trust in these solutions. As a result, unclear validation standards and regulatory hurdles continue to restrict broader adoption and growth in the digital therapeutics market.

Opportunity:

Advancements in personalization and AI technologies

Progress in artificial intelligence is opening new possibilities for customized OCD-focused digital therapeutics. These systems can evaluate user patterns and deliver tailored interventions for individuals managing Obsessive-Compulsive Disorder. Using approaches like Cognitive Behavioral Therapy, platforms can modify therapy content and provide immediate feedback. Personalized experiences lead to better engagement and improved results. As AI technology continues to advance, digital therapeutics will become more adaptive and efficient, offering enhanced value to patients and healthcare providers while driving innovation and growth within the mental health treatment landscape.

Threat:

Intense market competition and fragmentation

High levels of competition and market fragmentation pose a threat to OCD-focused digital therapeutics. Many companies are offering solutions for Obsessive-Compulsive Disorder with similar functionalities, making it difficult to stand out. This crowded environment can result in pricing challenges and reduced profit margins. The absence of uniform standards across platforms can also confuse users and clinicians. As rivalry increases, smaller firms may find it hard to survive, while dominant players gain more control. This imbalance can restrict innovation and create obstacles for sustainable growth within the digital therapeutics landscape.

Covid-19 Impact:

The outbreak of COVID-19 played a crucial role in boosting the OCD-focused digital therapeutics market by increasing the need for mental health support. Heightened stress, social isolation, and concerns about cleanliness worsened symptoms in people with Obsessive-Compulsive Disorder. Due to lockdowns, access to traditional face-to-face therapy became limited, encouraging the use of digital treatment platforms. Both patients and healthcare professionals increasingly relied on telehealth and mobile-based solutions. Furthermore, rising investments and awareness around digital healthcare supported innovation, contributing to sustained growth and wider acceptance of digital therapeutics in the mental health sector globally.

The CBT-based digital modules segment is expected to be the largest during the forecast period

The CBT-based digital modules segment is expected to account for the largest market share during the forecast period because of their established credibility and effectiveness. These solutions offer structured and scientifically validated methods to address symptoms of Obsessive-Compulsive Disorder. Their flexibility allows them to be used independently or alongside professional guidance, increasing accessibility for users. The consistent results, standardized frameworks, and ease of implementation across digital platforms strengthen their position. As a result, they are widely trusted and adopted, making them the leading segment within the evolving landscape of digital therapeutics for OCD management.

The freemium-to-premium upgrade models segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the freemium-to-premium upgrade models segment is predicted to witness the highest growth rate because they effectively balance accessibility and monetization. By offering free entry-level services, individuals managing Obsessive-Compulsive Disorder can explore the platform without financial commitment. Once users recognize the benefits, many transition to paid plans for additional features and personalized care. This model enhances engagement, builds trust, and encourages long-term usage. Its flexibility and scalability make it well-suited to modern digital behaviour, driving rapid adoption and positioning it as a key growth segment within the digital therapeutics ecosystem.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, owing to its well-established healthcare systems and strong adoption of advanced digital solutions. Awareness of Obsessive-Compulsive Disorder is relatively high, leading to increased demand for innovative treatment options. The region is supported by favorable regulations and significant investments in digital healthcare technologies. Incorporation of proven methods such as Cognitive Behavioral Therapy into digital platforms further strengthens outcomes. Additionally, widespread access to smartphones, internet connectivity, and insurance support ensures greater adoption, reinforcing North America's leading position in the market.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR due to increasing technological adoption and improving healthcare systems. Rising cases of Obsessive-Compulsive Disorder and greater awareness of mental health are boosting demand for accessible treatments. Countries such as India and China are actively promoting digital health through government initiatives and investments. Enhanced internet connectivity and smartphone usage further support market expansion. With a large underserved population and growing acceptance of digital solutions, the region offers significant opportunities for rapid and sustained growth.

Key players in the market

Some of the key players in OCD-Focused Digital Therapeutics Market include nOCD, LiveOCD Free, OCFree, GGtude, OCD.app, Treat My OCD, Quirk Health, Anxiety Canada, IOCDF, Woebot, Sanvello, MindShift CBT, OCD Challenge, BT Steps, Exposure Tracker, Dare Health, ClearFear and GGOC-AD.

Key Developments:

In August 2023, NOCD and Talkiatry announced a strategic partnership aimed at improving access and outcomes for people suffering from OCD by seamlessly connecting them to both therapists and psychiatrists who specialize in treating the disorder. OCD is a relatively common mental health condition, affecting approximately 2.3% of the global population, and is characterized by recurring unwanted thoughts and repetitive behaviors.

In October 2020, Sanvello Health, Inc announced a new partnership with the Chicago Bulls. The partnership will raise awareness and increase access to mental health services both internally at the Bulls for players, coaches and front office staff, and externally for Bulls fans and select community partners. With this partnership, Bulls players, coaches and front office staff will be offered access to the full suite of Sanvello's services with Sanvello Premium.

Therapeutic Approaches Covered:

  • CBT-Based Digital Modules
  • ERP-Focused Platforms
  • Neurofeedback Solutions
  • AI-Driven Personalization Engines

Delivery Platforms Covered:

  • Mobile App Interfaces
  • Web-Portal Platforms
  • Immersive VR/AR Therapy Systems
  • Wearable-Linked OCD Tools

Business Models Covered:

  • Patient Subscription Plans
  • Single-License Purchase
  • Freemium-to-Premium Upgrade Models
  • Institutional Licensing Contracts

End Users Covered:

  • Children & Adolescents with OCD
  • Adult OCD Patients
  • Clinical Professionals
  • Institutional Adopters

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global OCD Focused Digital Therapeutics Market, By Therapeutic Approach

  • 5.1 CBT-Based Digital Modules
  • 5.2 ERP-Focused Platforms
  • 5.3 Neurofeedback Solutions
  • 5.4 AI-Driven Personalization Engines

6 Global OCD Focused Digital Therapeutics Market, By Delivery Platform

  • 6.1 Mobile App Interfaces
  • 6.2 Web-Portal Platforms
  • 6.3 Immersive VR/AR Therapy Systems
  • 6.4 Wearable-Linked OCD Tools

7 Global OCD Focused Digital Therapeutics Market, By Business Model

  • 7.1 Patient Subscription Plans
  • 7.2 Single-License Purchase
  • 7.3 Freemium-to-Premium Upgrade Models
  • 7.4 Institutional Licensing Contracts

8 Global OCD Focused Digital Therapeutics Market, By End User

  • 8.1 Children & Adolescents with OCD
  • 8.2 Adult OCD Patients
  • 8.3 Clinical Professionals
  • 8.4 Institutional Adopters

9 Global OCD Focused Digital Therapeutics Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 nOCD
  • 12.2 LiveOCD Free
  • 12.3 OCFree
  • 12.4 GGtude
  • 12.5 OCD.app
  • 12.6 Treat My OCD
  • 12.7 Quirk Health
  • 12.8 Anxiety Canada
  • 12.9 IOCDF
  • 12.10 Woebot
  • 12.11 Sanvello
  • 12.12 MindShift CBT
  • 12.13 OCD Challenge
  • 12.14 BT Steps
  • 12.15 Exposure Tracker
  • 12.16 Dare Health
  • 12.17 ClearFear
  • 12.18 GGOC-AD

List of Tables

  • Table 1 Global OCD Focused Digital Therapeutics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global OCD Focused Digital Therapeutics Market Outlook, By Therapeutic Approach (2023-2034) ($MN)
  • Table 3 Global OCD Focused Digital Therapeutics Market Outlook, By CBT-Based Digital Modules (2023-2034) ($MN)
  • Table 4 Global OCD Focused Digital Therapeutics Market Outlook, By ERP-Focused Platforms (2023-2034) ($MN)
  • Table 5 Global OCD Focused Digital Therapeutics Market Outlook, By Neurofeedback Solutions (2023-2034) ($MN)
  • Table 6 Global OCD Focused Digital Therapeutics Market Outlook, By AI-Driven Personalization Engines (2023-2034) ($MN)
  • Table 7 Global OCD Focused Digital Therapeutics Market Outlook, By Delivery Platform (2023-2034) ($MN)
  • Table 8 Global OCD Focused Digital Therapeutics Market Outlook, By Mobile App Interfaces (2023-2034) ($MN)
  • Table 9 Global OCD Focused Digital Therapeutics Market Outlook, By Web-Portal Platforms (2023-2034) ($MN)
  • Table 10 Global OCD Focused Digital Therapeutics Market Outlook, By Immersive VR/AR Therapy Systems (2023-2034) ($MN)
  • Table 11 Global OCD Focused Digital Therapeutics Market Outlook, By Wearable-Linked OCD Tools (2023-2034) ($MN)
  • Table 12 Global OCD Focused Digital Therapeutics Market Outlook, By Business Model (2023-2034) ($MN)
  • Table 13 Global OCD Focused Digital Therapeutics Market Outlook, By Patient Subscription Plans (2023-2034) ($MN)
  • Table 14 Global OCD Focused Digital Therapeutics Market Outlook, By Single-License Purchase (2023-2034) ($MN)
  • Table 15 Global OCD Focused Digital Therapeutics Market Outlook, By Freemium-to-Premium Upgrade Models (2023-2034) ($MN)
  • Table 16 Global OCD Focused Digital Therapeutics Market Outlook, By Institutional Licensing Contracts (2023-2034) ($MN)
  • Table 17 Global OCD Focused Digital Therapeutics Market Outlook, By End User (2023-2034) ($MN)
  • Table 18 Global OCD Focused Digital Therapeutics Market Outlook, By Children & Adolescents with OCD (2023-2034) ($MN)
  • Table 19 Global OCD Focused Digital Therapeutics Market Outlook, By Adult OCD Patients (2023-2034) ($MN)
  • Table 20 Global OCD Focused Digital Therapeutics Market Outlook, By Clinical Professionals (2023-2034) ($MN)
  • Table 21 Global OCD Focused Digital Therapeutics Market Outlook, By Institutional Adopters (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.